# DHEA-S Women 70+ Years Enrichment Report

**Score Item:** DHEA-S - Mulheres (70+ anos)
**ID:** e622f011-e92d-459e-9f4a-af435f26ea74
**Date:** 2026-01-28

---

## Executive Summary

Successfully enriched the DHEA-S score item for women 70+ years with comprehensive clinical content in Portuguese and 4 peer-reviewed scientific articles focusing on elderly women, mortality, frailty, and supplementation trials.

---

## Scientific Articles Added

### 1. Meta-Analysis (2025)
**Title:** Impact of DHEA supplementation on testosterone and estradiol levels in postmenopausal women: a meta-analysis of randomized controlled trials assessing dose and duration effects

**Authors:** He SY, Lu K, Zhang L, Cao H, Tang X, Zhang X
**Journal:** Diabetology & Metabolic Syndrome
**DOI:** 10.1186/s13098-025-01770-0
**Type:** Meta-analysis

**Key Findings:**
- Analysis of 21 randomized controlled trials
- Doses ≥50 mg/day significantly increase testosterone (WMD: 29.65 ng/dL) and estradiol (WMD: 8.65 pg/mL)
- Effects more pronounced in women ≥60 years and treatments ≥26 weeks
- Clinically minimal estradiol increase requires careful risk-benefit assessment

---

### 2. Prospective Cohort Study (2006)
**Title:** DHEAS Levels and Mortality in Disabled Older Women: The Women's Health and Aging Study I

**Authors:** Cappola AR, Xue QL, Walston JD, Leng SX, Ferrucci L, Guralnik J, Fried LP
**Journal:** Journal of Gerontology A: Biological Sciences and Medical Sciences
**DOI:** 10.1093/gerona/61.9.957
**Type:** Research article

**Key Findings:**
- 539 disabled women aged 65-100 years, 5-year follow-up
- U-shaped relationship: both very low and very high DHEAS levels associated with >2-fold increased mortality
- Optimal DHEAS level for lowest mortality: 41 μg/dL
- Lower DHEAS correlated with cardiovascular deaths; higher DHEAS with cancer mortality
- Critical evidence against indiscriminate supplementation

---

### 3. Review Article (2013)
**Title:** A Review of Age-Related Dehydroepiandrosterone Decline and Its Association with Well-Known Geriatric Syndromes: Is Treatment Beneficial?

**Authors:** Samaras N, Samaras D, Frangos E, Forster A, Philippe J
**Journal:** Rejuvenation Research
**DOI:** 10.1089/rej.2013.1425
**Type:** Review

**Key Findings:**
- By age 70-80 years, DHEA levels may be as low as 10-20% of young adult values
- Associations documented with musculoskeletal health, cardiovascular disease, sexual function, mood, and cognition
- Mixed results for supplementation efficacy
- Insufficient evidence for definitive treatment recommendations

---

### 4. Randomized Controlled Trial (2010)
**Title:** Dehydroepiandrosterone Combined with Exercise Improves Muscle Strength and Physical Function in Frail Older Women

**Authors:** Kenny AM, Boxer RS, Kleppinger A, Brindisi J, Feinn R, Burleson JA
**Journal:** Journal of the American Geriatrics Society
**DOI:** 10.1111/j.1532-5415.2010.03019.x
**Type:** Research article

**Key Findings:**
- Double-blind RCT in 99 frail women (mean age 76.6 years)
- DHEA 50 mg/day + low-intensity exercise (chair aerobics/yoga) for 6 months
- Significant improvements in lower extremity strength and physical function
- No serious adverse effects
- No changes in bone mineral density

---

## Clinical Content Created

### Clinical Relevance (1,571 characters)
Comprehensive overview covering:
- Unique decline pattern in women 70+ (10-20% of young adult levels)
- U-shaped mortality curve (RR >2.0 for extremes, optimal ~41 μg/dL)
- Associations with frailty, sarcopenia, physical function
- Evidence from controlled trials in frail elderly women
- Gender differences (weaker association with cardiovascular mortality vs. men)
- Individualized monitoring approach

### Patient Explanation (1,377 characters)
Patient-friendly Portuguese explanation including:
- Natural decline with aging (physiological process)
- Non-linear relationship with health outcomes
- Associations with muscle strength and functional capacity
- Evidence from frail elderly women studies
- Not indicated for all women - individualized assessment required
- Importance of medical supervision for supplementation decisions

### Conduct (2,210 characters)
Detailed clinical protocols covering:

**Laboratory Interpretation:**
- Age-adjusted reference ranges (15-70 μg/dL may be physiological)
- Optimal level ~41 μg/dL based on mortality data
- Context-dependent interpretation (comorbidities, frailty)

**Clinical Assessment:**
- Frailty criteria (Fried)
- Sarcopenia assessment (grip strength, DEXA)
- Functional tests (gait speed, SPPB)
- Oncological history (hormone-dependent cancers)
- Cardiovascular risk

**Supplementation Evidence:**
- 2025 meta-analysis: ≥50mg/day dosing, ≥26 weeks duration
- RCT in frail women: 50mg/day + exercise improved strength

**Potential Indications:**
- Documented frailty
- Sarcopenia
- Very low DHEA-S (<15 μg/dL) with symptoms
- Preserved adrenal function

**Contraindications:**
- Hormone-dependent cancer history
- Elevated DHEA-S (>100 μg/dL, U-curve risk)
- Untreated primary adrenal insufficiency

**Supplementation Protocol:**
- Initiate 25-50mg/day
- Always combine with supervised exercise
- Monitor DHEA-S, estradiol, testosterone, liver function at 3 and 6 months
- Reassess clinical benefits after 6 months
- Indiscriminate supplementation NOT recommended

---

## Verification Results

```
clinical_relevance_chars: 1,571
patient_explanation_chars: 1,377
conduct_chars: 2,210
linked_articles_count: 13 (4 new + 9 existing MFI lectures)
```

All fields within target ranges:
- Clinical relevance: 1500-2000 ✓
- Patient explanation: 1000-1500 ✓
- Conduct: 1500-2500 ✓

---

## Key Clinical Insights

1. **U-Shaped Mortality Curve:** Critical finding that both very low and very high DHEA-S levels in elderly women associate with increased mortality - optimal level ~41 μg/dL

2. **Gender Differences:** Unlike men, women show weaker associations between low DHEA-S and cardiovascular mortality, but higher DHEA-S may link to cancer deaths

3. **Frailty Context:** Most compelling evidence for supplementation comes from studies in frail elderly women combining DHEA with exercise

4. **Dose and Duration:** Recent meta-analysis confirms ≥50mg/day for ≥26 weeks needed for hormonal effects in women ≥60 years

5. **Individualized Approach:** Given U-shaped curve and mixed evidence, supplementation requires careful patient selection and monitoring

---

## Sources

- [Impact of DHEA supplementation - Meta-analysis 2025](https://pmc.ncbi.nlm.nih.gov/articles/PMC12231631/)
- [DHEAS Levels and Mortality in Disabled Older Women](https://pmc.ncbi.nlm.nih.gov/articles/PMC2645634/)
- [Age-Related DHEA Decline Review](https://pmc.ncbi.nlm.nih.gov/articles/PMC3746247/)
- [DHEA + Exercise in Frail Women RCT](https://pubmed.ncbi.nlm.nih.gov/20863330/)

---

## Files Generated

- `/home/user/plenya/enrich_dheas_women_70plus.sql` - Enrichment SQL script
- `/home/user/plenya/DHEAS_WOMEN_70PLUS_ENRICHMENT_REPORT.md` - This report

---

**Status:** ✅ COMPLETED SUCCESSFULLY
